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Abstract
Genetic factors have an important role in the pathophysiology of endometriosis. In addition,
abnormalities in lipid profile and intrinsic inflammatory status are associated with disease
progression. The purpose of this study was to evaluate the effect of the I405V polymorphism of
cholesteryl ester transfer protein (CETP) gene and lipid profile with the risk of endometriosis in
women. Ninety-seven women with laparoscopy-diagnosed endometriosis were recruited for
this study, and 107 patients with no evidence of endometriosis confirmed by laparoscopy
served as controls. Samples were analyzed for polymorphism of the CETP gene using
polymerase chain reaction–restriction fragment length polymorphism-based methods. After
adjustment for body mass index, high-density lipoprotein-C and low-density lipoprotein-C, the
risk of endometriosis in patients with normal genotype homozygous was more of the rare allele
(p50.001, odds ratio¼ 0.21, 95% confidence interval¼ 0.09–0.45). Our results suggest that
I405V polymorphism of CETP gene plays an important role as independent factor in the risk of
endometriosis in women.
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Introduction
Endometriosis is a common benign gynecological disorder that is
characterized by the development of the endometrial tissue
outside the uterus [1]. Endometrial implants are most commonly
found on the visceral peritoneal surfaces. However, the tissue with
endometrial abnormalities may also appear on the bladder or
bowel [2]. The disease is diagnosed by laparoscopy with or
without biopsy for histological diagnosis [2,3]. According to its
extent, endometriosis was classified as stages I (minimum), II
(mild), III (moderate) and IV (severe) [4]. Despite extensive
research, the definitive cause of endometriosis is still unknown
[5,6]. Studies showed that elevation of serum lipoprotein in
patients with endometriosis is associated with an increased risk of
cardiovascular disease [7]. CETP is a key protein in plasma
lipoprotein metabolism, particularly as a modulator of high-
density lipoprotein (HDL)-C levels. The (cholesteryl ester
transfer protein) CETP gene is located on chromosome 16 and
consists of 16 exons [8]. The gene possesses several different
single-nucleotide polymorphisms (SNPs) has no sense. One of
these polymorphisms is I405V polymorphism (rs5882) that is the
substitution of valine to isoleucine at codon 405 in exon 14 [8].
Melo et al. [9] suggested that disruption of lipid profile with
elevated low-density lipoprotein (LDL) and non-HDL may
increase oxidative stress and inflammation in the peritoneal
fluid and increase the risk of endometriosis. This hypothesis
supports that women with endometriosis have a dyslipidemia that
could provide a suitable pathological substrate for inflammatory
process and oxidative stress in endometrial tissue [10].
Several studies evaluated the impact of CETP I405V SNP on
myocardial infarction risk [11,12], but there are no studies
conducted. The purpose of this study was to determine the
prevalence of I405V polymorphism of CETP gene in women with
endometriosis with respect to the control group and concurrent
evaluation of this gene polymorphism on lipid profile and the risk
of endometriosis.
Materials and methods
Subjects
In this cross-sectional study, women (aged 18–42 years) with
chronic pelvic pain or infertility referred to the Kosar Hospital in
Qazvin for diagnostic laparoscopy between April 2011 and April
2012 were consecutively included. Among 310 women, 204 were
eligible and consented to participation in the study (Figure 1). The
study was approved by the ethics committee of Qazvin University
of Medical Sciences. To obtain more homogeneous population
and verifying that no endometriosis is present, controls were also
selected from women undergoing laparoscopy. A total of 97
patients had surgical and histological evidence of endometriosis,
while 107 patients without the disease served as controls (women
with uterine myoma, dermoid cyst, paraovarian cyst, serous cyst
and healthy women). Among the endometriosis patients, 10
patients were diagnosed with stage I, 13 patients with stage II, 35
patients with stage III and 39 patients with stage IV.
Endometriosis condition was confirmed by diagnostic laparos-
copy or laparotomy in both groups. None of the patients had
received hormone therapy during the past 1 year. In addition,
women who had received anti-inflammatory drug and
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contraceptives in the past 3 months, or had urological disease,
endocrine disorders, familial dyslipidemia and chronic inflam-
matory were not included in the study.
Lipid profile analysis
Total cholesterol, HDL-C and triglyceride (TG) were determined
by standard enzymatic methods. LDL-C was calculated by
Friedewald formula: LDL-C¼ total cholesterol (TC) (HDL-
CþTG/5) [13].
Genotyping
Genomic DNA was extracted from the peripheral blood leuko-
cytes by Qiagen kit (Valencia, CA, USA). A 308-bp sequence of
the CETP gene was amplified by PCR in a DNA thermal cycle
(ABI Veriti, Foster City, CA, USA) by using oligonucleotide
primers: F: 50GCAGAACAGTACTGGCCAAGCAGCG-30 and
R: 50GCGGTGATCATTGACTGCAGGAAGCTCTGTA-30.
DNA fragment
The PCR conditions were 96 C for 5 min, 36 cycles at 95 C for
30 s, 55 C for 30 s, 72 C for 30 s, followed by 72 C for 6 min
[14]. Restriction of the PCR product with the RsaI enzyme results
in fragment sizes of 268/40 bp in rare homozygotes, 308/268/
40 bp in hetrozygotes and 308 bp in common homozygotes.
Samples were electrophoresed in 3% agarose gel, and then the gel
was visualized with ethidium bromide.
Statistical analysis
Values were presented as the mean standard deviation, and
statistical significance was defined as p50.05. Statistically
significant differences in means between genotypes were assessed
by t-test. Logistic regression analyses were performed to evaluate
genotypes with respect to the presence of endometriosis
as dependent variable. All analyses were carried out using
SPSS 11.0 software (SPSS Inc, Chicago, IL, USA).
Results
Demographic and metabolic parameter of patients and controls
are shown in Table 1: mean age (endometriosis: 29.8 5.4 years
versus control: 29.5 5.5 years, p¼ 0.66), body mass
index (BMI) (endometriosis: 25.1 3.3 kg/m2 versus con-
trol: 26.9 3.9 kg/m2, p¼ 0.001) and waist circumference (endo-
metriosis: 80.6 9.1 cm versus control: 81.2 9.7 cm, p¼ 0.69).
The TC level of the endometriosis group was higher than the
control group (216 38 mg/dL versus 175 30 mg/dL,
p50.0001) and also the LDL-C level of the endometriosis
group was higher (130 22 mg/dL versus 101 20 mg/dL,
p50.0001). Similarly, HDL-C levels were higher in the endo-
metriosis group (46 10 mg/dL versus 40 9 mg/dL, p50.001).
TG levels were higher in the endometriosis group but were not
significantly different between the groups (128 48 mg/dL versus
127 47 mg/dL, p¼ 0.86). The genotype distributions of both
groups were in Hardy–Weinberg equilibrium (both p40.05). Chi-
square analysis between genetic groups identified that normal
genotypes have more susceptibility than those carrying rare
alleles (p50.001). The distribution of genotypes was different
between the endometriosis group and the control group (Table 2).
Using logistic regression analysis the risk of endometriosis in
different genetic groups was calculated (Table 2). The analysis
showed that in normal individuals with homozygous genotype, the
risk of endometriosis was more than other groups. Moreover, the
analysis, after adjustment factors such as BMI, HDL-C and LDL-
C, showed that the risk of endometriosis in patients with normal
genotype homozygous was more of the rare allele (p50.001, odds
ratio¼ 0.21, 95% confidence interval¼ 0.09–0.45). Analysis of
Figure 1. Flowchart of study population.
Table 1. Metabolic parameters of patients with endometriosis versus
control.
Control
(n¼ 107)
Endometriosis
(n¼ 97) p
Age, years 29.5 5.5 29.8 5.4 0.66
Body mass index, kg/m2 26.9 3.9 25.1 3.3 0.001
Waist, cm 81.2 9.7 80.6 9.1 0.69
Cholesterol, mg/dL 175 30 216 38 50.001
Triglyceride, mg/dL 127 47 128 48 0.86
HDL-C, mg/dL 40 9 46 10 50.001
LDL-C, mg/dL 101 20 130 22 50.001
Values are mean standard deviation.
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variance showed that in women with endometriosis there is an
increase in TC, LDL-C and HDL-C compared to the control
(p50.001) (Table 3).
Discussion
Endometriosis is associated with increased inflammation in the
peritoneal cavity [15]. In this study, we have shown that women
with endometriosis have a dyslipidemia compared to control
subjects. These findings were consistent with previous studies
[9,10]. Oxidized LDL (oxLDL) can increase endothelial damage
and promote the migration of leukocytes and macrophages.
Leukocytes and macrophages cause the release of cytokines,
platelet accumulation and the release of chemotactic factors [15].
Polak et al. [16] showed an increased oxLDL in the peritoneal
fluid of women with endometriosis, in advanced stages.
This finding suggests that endometriosis may increase the risk
for atherogenesis that can occur in disease progression; however,
this correlation has not yet been confirmed [11]. Our study
demonstrated higher HDL-C concentrations in patients with
endometriosis.
This study suggested that CETP gene polymorphism has
important relation with the risk of endometriosis. In this study, the
frequency of 405V allele in control group was similar to Asians
and more than that in Caucasians and African-American popu-
lations [15]. Humans with homozygous CETP deficiency have an
increased HDL-C levels and decreased LDL-C levels [8,15,17].
Our research has showed that in subjects with I405V polymorph-
ism CETP gene, the risk of endometriosis is lower than normal
homozygous individuals.
Moreover, our findings suggested that in woman with 405 V
allele, TC and LDL-C levels are less than normal homozygous
genotype. Cholesterol and LDL-C, as inflammatory risk factors,
can be involved in the occurrence and severity of disease, which
may indicate beneficial effects of mutation in this gene.
The sample size in this study was relatively small due to financial
constraints. However, the preliminary results suggest it for further
studies. The main limitation of this study was the relatively small
sample size and the absence of data on HDL subclass and LDL
particle size. Another limitation was that CETP activity was not
obtained.
In conclusion, this study reported for the first time a significant
positive correlation between CETP gene polymorphism with the
risk of endometriosis. Despite the tendency to decrease endomet-
riosis risk with 405 allele, larger studies are warranted to confirm
these observations and to further study the interaction between
CETP genotype and endometriosis development.
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